This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Biotech Stocks Facing FDA Approval

Mannkind (MNKD)

Drug/indication: Afrezza for diabetes

Approval decision date: Unknown

The Jan. 16 FDA approval decision date for Afrezza was extended because inspections at an insulin manufacturing facility were not yet completed, according to Mannkind. How long the FDA will take to complete its inspection and issue an approval decision for Afrezza, an inhaled insulin device, is not known. Last month, Mannkind executives expressed confidence that the FDA would be able to complete its review within weeks, but that timeline is already past due.
2 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
CTIC $1.61 0.63%
DNDN $0.06 -6.02%
MNKD $3.88 -1.00%
SLXP $172.81 0.09%
XNPT $6.89 3.30%


Chart of I:DJI
DOW 16,478.25 -164.76 -0.99%
S&P 500 1,976.96 -11.91 -0.60%
NASDAQ 4,808.28 -20.0450 -0.42%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs